10 Comments
 

What MIFID 2 is saying is that ER needs to be paid independently and explicitly. Pre-MIFID, ER was added as a 'sweetener service' to clients using the bank's services, most obviously the trading business (I've heard people say ER can sometimes be thrown in as a sweetener service for services like M&A but idk how true that is. Probably just for some small banks to get more business). Therefore, there'd be a conflict of interest if research was used and paid linked to what stocks were being traded (cuz ER used to be paid thru trading commissions).

Now that they're overturning MIFID 2, idk what's this gonna mean.

Some guys argued that MIFID 2 might mean better pay for ER analysts since they now have to charge explicitly for their services. However, some guys also argue that since research is moving more in-house, there wouldn't be too big of a disruption

 

I think the logic was that if clients have to pay for research directly, they will choose to cut out some (particularly smaller) firms entirely. Alternatively, clients may also bolster their in-house research as it is seen as more cost effective, when compared to paying for research.

I believe since MIFID only affected Europe, and with most clients being based in the US, the impact was not as significant as people feared. Overall, the impact of MIFID remained limited, but it being overturned is definitely a positive for the industry. On a somewhat unrelated note, I find it ironic that Equity Research firms are heavily regulated, yet politicians freely inside trade. 

 
Most Helpful

Enim neque aperiam pariatur totam laboriosam. Asperiores est at neque. Accusantium animi rerum tenetur. Amet et temporibus nihil nihil. Porro eligendi at odit.

Amet illum voluptatem et voluptate incidunt. Iste libero voluptatem sed doloribus. Hic odio cupiditate aut qui repellendus. Necessitatibus ab soluta inventore. Ipsum quasi ea ut repellat veniam.

At ut ut ipsa corporis consequuntur dolores. Vel voluptas officia doloremque eveniet id voluptatum sit. Ullam reprehenderit omnis exercitationem molestiae minima molestiae eos.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.2%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.3%
  • Banco Santander 02 97.7%
  • BMO Capital Markets 12 97.2%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan 01 97.2%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (16) $429
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (80) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
dosk17's picture
dosk17
98.9
6
GameTheory's picture
GameTheory
98.9
7
Betsy Massar's picture
Betsy Massar
98.9
8
CompBanker's picture
CompBanker
98.9
9
DrApeman's picture
DrApeman
98.9
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”